WP4 will validate clinically relevant biological substrates for social withdrawal and cognitive function through the use of quantitative technologies including behavioural, functional MRI and electroencephalography (EEG) paradigms. This will be achieved by conducting a clinical investigation in a multi-center clinical study to evaluate the relationship between social withdrawal and cognitive performance in SZ and AD patients.
